Diabetes, use of metformin, and the risk of meningioma

URN to cite this document:: urn:nbn:de:bvb:355-epub-365375
DOI to cite this document:: 10.5283/epub.36537

Leitzmann, Michael F. ; Seliger, Corinna ; Meier, Christoph R. ; Becker, Claudia

; Jick, Susan S. ; Proescholdt, Martin ; Bogdahn, Ulrich ; Hau, Peter

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(698kB)

Date of publication of this fulltext: 19 Jan 2018 11:20

Alternative links to fulltext:DOI Publisher Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Background Metformin is a commonly used oral antidiabetic agent that has been associated with decreased cancer risk. However, data regarding the association between metformin use and the risk of meningioma are unavailable. Methods We conducted a matched case-control analysis using data from the U. K.-based Clinical Practice Research Datalink (CPRD) to analyse diabetes status, duration of ...